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Abstract:  Recently,  considerable  attention  has  been  focused  on  dietary  and  medicinal 
phytochemicals  that  inhibit,  reverse  or  retard  diseases  caused  by  oxidative  and 
inflammatory  processes.  Vernonia  amygdalina  is  a  perennial  herb  belonging  to  the 
Asteraceae  family.  Extracts  of  the  plant  have  been  used  in  various  folk  medicines  as 
remedies against helminthic, protozoal and bacterial infections with scientific support for 
these claims. Phytochemicals such as saponins and alkaloids, terpenes, steroids, coumarins, 
flavonoids, phenolic acids, lignans, xanthones, anthraquinones, edotides and sesquiterpenes 
have  been  extracted  and  isolated  from  Vernonia  amygdalina.  These  compounds  elicit 
various biological effects including cancer chemoprevention. Garcinia kola (Guttiferae) 
seed,  known  as  ―bitter  kola‖,  plays  an  important  role  in  African  ethnomedicine  and 
traditional hospitality. It is used locally to treat illnesses like colds, bronchitis, bacterial and 
viral infections and liver diseases. A number of useful phytochemicals have been isolated 
from the seed and the most prominent of them is the Garcinia bioflavonoids mixture called 
kolaviron.  It  has  well-defined  structure  and  an  array  of  biological  activities  including 
antioxidant,  antidiabetic,  antigenotoxic  and  hepatoprotective  properties.  The 
chemopreventive properties of Vernonia amygdalina and Garcinia biflavonoids have been 
attributed to their abilities to scavenge free radicals, induce detoxification, inhibit stress 
response proteins and interfere with DNA binding activities of some transcription factors.  
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1. Introduction 
There  has  been  a  great  deal  of  interest  recently  in  the  role  of  complementary  and  alternative 
medicines  for  the  treatment  of  various  acute  and  chronic  diseases  [1].  Of  the  various  classes  of 
phytochemicals,  interest  has  focused  on  the  anti-inflammatory  and  antioxidant  properties  of 
polyphenols found in various botanical agents. Plants vegetables and spices used in folk and traditional 
medicine  have  gained  wide  acceptance  as  one  of  the  main  sources  of  prophylactic  and 
chemopreventive drug discovery and development [1]. 
Indeed, fruits and plants are rich sources of phenolic compounds and have been recognized to 
possess  a  wide  range  of  properties  including  antioxidant,  antibacterial,  anti-inflammatory, 
hepatoprotective and  anticarcinogenic actions. Many  of the  biological  functions of flavonoids  and 
phenolic compounds have been attributed to their free radical scavenging, metal ion chelating and 
antioxidant activities [2,3]. Antioxidant phenolic agents have been implicated in the mechanisms of 
chemoprevention which refers to the use chemical substances of natural origin or synthetic to reverse, 
retard or delay the multistage carcinogenesis process. 
Vernonia amygdalina, commonly known as bitter leaf, is a shrub that grows up to 3 meters high in 
the African tropics and other parts of Africa, particularly, Nigeria, Cameroon and Zimbabawe. It is 
reputed to have several health benefits. The organic fraction extracts of the plant was shown to possess 
cytotoxic effects towards human carcinoma cells of the nasopharynx [4]. It is effective against amoebic 
dysentery  [5],  gastrointestinal  disorders  [6],  and  has  antimicrobial  and  antiparasitic  activities  [7,8]. 
Figure 1 depicts the various traditional uses of Vernonia amygdalina. The biologically-active compounds 
of  Vernonia  amygdalina  are  saponins  and  alkaloids  [9],  terpenes,  steroids,  coumarins,  flavonoids, 
phenolic acids, lignans, xanthones and anthraquinone [10], edotides [11] and sesquiterpenes [4]. 
Garcinia Kola is a medium sized tree found in the moist forest and widely distributed throughout 
West and Central Africa. The edible nut is highly valued in these countries [12]. The seed, commonly 
known as bitter kola, is a masticatory and is a major kola substitute offered to guests at home and 
shared at social ceremonies. The seeds are used in folk medicine and in many herbal preparations for 
the  treatment  of  ailments  such  as  laryngitis,  liver  disorders,  and  bronchitis  [13].  The  biflavonoid 
mixture isolated from the seeds of Garcinia kola is known as kolaviron.  
Various extracts of Garcinia kola have been found to elicit a number of biochemical properties 
including  hepatoprotection,  antidiabetic  properties  and  antigenotoxic  potentials.  The  focus  of  this 
review is on the antioxidative and chemopreventive properties of Vernonia amygdalina and Garcinia 
bioflavonoids from the seed of Garcinia kola. Int. J. Environ. Res. Public Health 2011, 8        2535 
 
Figure 1. Traditional uses of Vernonia amygdalina (Bitter leaf). 
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2. Vernonia amygdalina (Asteraceae) 
Vernonia  amygdalina,  a  member  of  the  Asteraceae  family,  is  a  small  shrub  that  grows  in  the 
tropical Africa with petiolate leaf of about 6 mm diameter and elliptic shape. However, in contrast to 
the 1–3 meters described as the height of the tree by some authors [14-16], the species found around 
the Department of Wildlife and Fisheries, University of Ibadan, Nigeria are tall trees of greater than  
6 metres in height [17]. It is commonly called “bitter leaf” because of its bitter taste. The bitterness 
can, however, be abated by boiling or by soaking the leaves in several changes of water. In Nigeria, it 
is known variously as ―Ewuro‖ in Yoruba language, ―Onugbu‖ in Igbo language, ―Oriwo‖ in Bini 
language, ―Ityuna‖ in Tiv, ―Chusar doki or fatefate‖ in Hausa, while it is known as ―Etidot‖ in Cross 
River State of Nigeria. The bitter taste is due to anti-nutritional factors such as alkaloids, saponins, 
tannins, and glycosides [18]. The leaves are used as green leafy vegetable and may be consumed either 
as a vegetable (leaves are macerated in soups) or aqueous extracts used as tonics for the treatment of 
various illnesses [14]. In the wild, chimpanzees have been observed to ingest the leaves when suffering 
from parasitic infections [19-21]. Many herbalists and native doctors in Africa recommend its aqueous 
extracts for their patients as treatment for varieties of ailments ranging from emesis, nausea, diabetes, 
loss of appetite, dysentery and other gastrointestinal tract problems to sexually transmitted diseases 
and diabetes mellitus among others [22] (Figure 1). Some of these and other uses have been verified 
experimentally and documented by various workers, thus providing scientific evidences to support 
many of these claimed health benefits [6,10,14,22-32].  Int. J. Environ. Res. Public Health 2011, 8        2536 
 
2.1. Botanical Classification 
The plant is scientifically classified as belonging to the Kingdom Plantae. It is an angiosperm, of 
the order Asterales, of the family Asteraceae, genus Vernonia, and species V. amygdalina. The full 
binomial name is Vernonia amygdalina Del. 
2.2. Compounds Isolated from Vernonia amygdalina 
Several investigators have isolated and characterized a number of chemical compounds with potent 
biological  activities  from  the  leaves  of  Vernonia  amygdalina.  Some  of  the  previously  isolated 
constituents in Vernonia amygdalina Del. include: sesquiterpene lactones [10,11,14], flavonoids like 
luteolin, luteolin 7-O-glucosides and luteolin 7-O-glucuronide [33], steroid glycosides [14,34,35], and 
vernonioside A, B, A1, A2, A3, B2, B3 and A4 [14,34-36]. Edotides from the aqueous extract of the 
plant  was  characterized  in  [10].  Very  recently,  Owoeye  et  al.  [37]  isolated  and  characterized  a 
sesquiterpene  lactone,  epivernodalol,  another  elemanolide  from  the  dichloromethane  fraction  of 
Vernonia amygdalina (Figure 2). Koul et al. [38] isolated the compound epivernodalol from another 
species of the plant called Vernonia lasiopus. Some of these compounds are listed in Table 1. 
Table 1. Bioactive compounds isolated from Vernonia amygdalina. 
Name of Compound  Class of Compound  Author (s) 
Vernodalin  Sesquiterpene lactone  Kupchan et al. (1969) [4] 
Vernomygdin  Sesquiterpene lactone  Kupchan et al. (1969) [4] 
Vernoniosides 
A1, A2, A3, B1 
Steroid Glucosides  Jisaka et al. (1992) [34] 
Vernoniosides 
A4, B2, B3 
Steroid Glucosides  Jisaka et al. (1993) [35] 
Vernoniosides 
D and E 
Steroid glycosides  Igile et al. (1995) [33] 
Vernodalol  Sesquiterpene lactone  Ganjian et al. 1983 [23]; Erasto et al. 2006 [16] 
Epivernodalol  Sesquiterpene lactone  Owoeye et al. (2010) [37] 
Figure 2. Some structures of compounds isolated from Vernonia amygdalina.  
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2.3. Traditional Uses of Vernonia amygdalina 
Leaves of this plant are used in Nigeria as a green vegetable or as a spice in soup, especially in the 
popular bitter-leaf soup. Such preparation includes freshly harvested leaves which are macerated with 
either cold or hot water to reduce the bitterness of the leaves to a desirable level. The latter are then 
added with other condiments for the soup while the water extract may be taken as a tonic to prevent 
certain illnesses. The leaves can be taken as an appetizer and the water extract as a digestive tonic [39]. 
These  are  largely  consumed  by  the  female  Hausas  in  their  belief  that  it  makes  them  more  
sexually attractive.  
In Northern Nigeria, it has been added to horse feed to provide a strengthening or fattening tonic 
called ‗Chusar Doki‘ in Hausa [40]. The leaves have also been used in Ethiopia as hops in preparing tela 
beer [41]. The leaves are widely used for fevers and are known as a quinine–substitute in Nigeria and 
some  other  African  countries  [25,39,42,43].  The  young  leaves  are  used  in  folk  medicine  as 
antihelmintic, antimalarial, laxative/purgative, enema, expectorant, worm expeller and fertility inducer 
in subfertile women. Some wild chimpanzees in Tanzania had been observed to use this plant for the 
treatment  of  parasite  related  diseases  [21,36].  Many  herbalists  and  naturopathic  doctors  have 
recommended the aqueous extracts for their patients as treatment for emesis, nausea, diabetes, loss of 
appetite-induced abrosia, dysentery and other gastrointestinal tract problems. 
2.4. Biological Activities of Vernonia amygdalina 
2.4.1. Antioxidant Activity 
Iwalewa  et  al.  [44]  reported  the  antioxidant  and  cytoprotective  activities  of  boiled,  cold,  and 
methanolic  extracts  of  nine  edible  vegetables  in  Southwest  Nigeria  which  were  evaluated  in  the  
1,1-diphenyl-2-picrylhydrazyl free radical assay and hemagglutination assay in bovine erythrocytes, 
respectively. While Crassocephalum rubens showed the highest antioxidant activity (56.5%), Solanum 
americanum  and  Vernonia  amygdalina  exhibited  significant  antioxidant  activity.  Subsequently,  
Iwalokun et al. [45] reported the antioxidant effects of an aqueous extract of Vernonia amygdalina 
leaves against acetaminophen-induced hepatotoxicity and oxidative stress in mice. Pre-administration 
of Vernonia amygdalina resulted in a dose-dependent reversal of acetaminophen-induced alterations of 
all  the  liver  function  parameters  and  suppressed  acetaminophen-induced  lipid  peroxidation  and 
oxidative  stress.  The  study  suggested  that  Vernonia  amygdalina  protected  against  acetaminophen-
induced hepatic damage in mice by antioxidant mechanisms. The antioxidant mechanism of Vernonia 
amygdalina has been justified by the recent studies of Adesanoye and Farombi [46]. In this study, 
Vernonia  amygdalina  protected  against  carbon  tetrachloride-induced  liver  injury  by  inducing 
antioxidant and phase 2 enzymes. 
The antioxidant activity of Vernonia amygdalina has been attributed to the presence of flavonoids, 
as  reported  by  Igile  et  al.  [33].  Using  spectroscopic  techniques,  the  study  had  isolated  and 
characterized the flavonoids occurring in Vernonia amygdalina. Three flavones were identified with 
chemical and spectroscopic techniques namely: luteolin, luteolin 7-O-β-glucuronoside, and luteolin  
7-O-β-glucoside.  Determination  of  the  antioxidant  activity  of  the  three  flavones  had  shown  that 
luteolin showed greater activity than the other two. Since flavonoids are established as possessing Int. J. Environ. Res. Public Health 2011, 8        2538 
 
antioxidant  activity  [47-52].  It  can  be  speculated  that  the  antioxidant  properties  of  Vernonia 
amygdalina can be attributed to the presence of these flavonoids. The advantage of this antioxidant 
property has been revealed in neurotoxic studies since it has been established that flavonoids can 
traverse  the  blood  brain  barrier  [53].  In  this  connection,  Owoeye  et  al.  [54]  reported  the 
neuroprotection of the cerebellum by the methanolic extract of Vernonia amygdalina leaves on the 
gamma-irradiated brain of Wistar rats. 
2.4.2. Chemopreventive Properties of Vernonia amygdalina 
Kupchan  et  al.  [11]  reported  the  inhibitory  activity  of  the  chloroform  extract  of  Vernonia 
amygdalina in vitro against cells derived from human carcinoma of the nasopharynx (KB) carried in 
tissue culture. Bioassay-guided fractionation of the extract yielded two compounds namely vernodalin 
(C19H20O7) and vernomygdin (C19H25O7), both of which had cytotoxic properties.  
Izevbigie et al. [10,28] reported that the aqueous extract was a potent inhibitor of cultured human 
breast tumour cells (MCF-7) growth in vitro. This may imply tumour stabilization or preventive effects 
in vivo. Applying the reverse-phase chromatography method, fractions of Vernonia amygdalina extract 
was found to inhibit DNA synthesis. Much more important was the findings that the physiological 
concentrations of the water-soluble Vernonia amygdalina extract potently inhibited DNA synthesis in 
a concentration-dependent manner both in the presence and absence of serum. Further studies reported 
that treatment of cells with various concentrations (3–100 µ g/mL of the same water-soluble extract 
potently inhibited cell growth of extracellular signal-regulated protein kinases 1 and 2 (ERKs 1/2) 
activities, DNA synthesis, and cell growth in a concentration-dependent manner. Izevbigie et al. [28] 
suggested  that  the  ERK  signaling  pathways  may  be  one  or  more  of  the  intracellular  targets  for 
Vernonia  amygdalina antineoplastic actions.  Assessing the chemotherapeutic efficacy  of  Vernonia 
amygdalina (VA) leaf extracts as anti-cancer agent against human breast cancer in vitro using the MTT 
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium  bromide]  and  alkaline  single  cell  gel 
electrophoresis (Comet) assays, respectively, Yedjou et al. [55] reported that Vernonia amygdalina 
treatment  moderately  (P  <  0.05)  reduced  cellular  viability  and  induced  minimal  DNA  damage  in  
MCF-7 cells. This provided evidence that Vernonia amygdalina extracts represent a DNA-damaging 
anti-cancer agent against breast cancer and its mechanisms of action functions, at least in part, through 
minimal DNA damage and moderate toxicity in tumors cells. In mechanistic terms studies have shown 
that V. amygdalina extract acts as a monofunctional inducer in MCF-7 breast cancer cells. Exposure of 
cells to low doses of V. amygdalina did not affect expression levels of CYP1A1/1A2 mRNA, but led 
to induction of microsomal epoxide hydrolase (mEH), thus supporting the chemotherapeutic potential 
of Vernonia amygdalina [56]. 
Applying  bioassay-guided  fractionation  of  the  methanolic  extract  of  V.  amygdalina  leaves,  
Owoeye  et  al.  [37],  isolated  and  characterized  a  known  sesquiterpene  lactone  compound, 
epivernodalol  (C20H24O8)  for  the  first  time  in  this  plant  applying  spectroscopic  methods.  In  vitro 
growth inhibitory and cytotoxic evaluation of the extract, its fractions and epivernodalol against skin 
melanoma  cell  line (HT-144)  was carried out  by the Sulforhodamine  B (SRB)  assay.  The results 
showed that the extract, the dichloromethane fraction, and epivernodalol (Table 2) were active against 
skin melanoma cell line (HT-144) (Figure 3).  Int. J. Environ. Res. Public Health 2011, 8        2539 
 
Table  2.  Activity  of  Vernonia  amygdalina  Del.  extract,  fractions,  Epivernodalol  and 
doxorubicin against HT-144 (skin melanoma) cell line. 
Code  GI50 (µ g/mL)  TGI (µ g/mL)  LC50 (µ g/mL) 
MEVA (extract)  86 ±  1.3  141.3 ±  4.7  199 ±  10.8 
VAD (fraction)  3.3 ±  0.3**  6.3 ±  0.3**  10.6 ±  0.8** 
VAP (fraction)  9.7 ±  2.3*  21.2 ±  5.4*  37.7 ±  4.4* 
Epivernodalol  1.76 ±  0.3**  7.33 ±  0.55**  22 ±  1.2** 
Doxorubicin  0.01 ±  0  0.07 ±  0.03  0.48 ±  0.1 
Each value represents the means ±  SD of three independent experiments. * Significantly different 
from  MEVA  (p  <  0.05).  **  Significantly  different  from  MEVA  (p  <  0.01).  GI50  =  Growth 
inhibition of 50% of the cells; TGI = Total growth inhibition. LC50 = Lethal concentration of the 
compound/extract that kills 50% of the cells. MEVA: methanolic extract of Vernonia amygdalina; 
VAP: petroleum ether fraction; VAD: dichloromethane fraction. (Adapted from Owoeye et al. [37]). 
Figure  3.  Each  value  represents  the  means  ±   SD  of  three  independent  experiments.  
GI50  =  Growth  inhibition  of  50%  of  the  cells;  TGI  =  Total  growth  inhibition;  
LC50 = Lethal concentration of the compound/extract that kills 50% of the cells; MEVA: 
methanolic  extract  of  Vernonia  amygdalina;  VAP:  petroleum  ether  fraction;  VAD: 
dichloromethane fraction. (Adapted from Owoeye et al. [37]). 
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The anticancer activity exhibited by epivernodalol could be explained by its being a sesquiterp ene 
lactone.  Rodriquez et  al.  [57]  described  the  mechanism  by  which  sesquiterpene  lactones  exhibit 
growth inhibition properties which depended on the structural configuration of the compound, namely 
the  presence  of  an  exocyclic  methylene  conjugated  to  the  gamma-lactone,  and  the  presence  of  a 
functional  group  such  as  hydroxyl  or  unsaturated  ketone  among  other  groups.  A  review  of  the 
epivernodalol molecule shows the attachment to its lactone an exocyclic methylene, and hydroxyl 
groups on carbons 6 and 18, in addition to the ketone groups attached to carbons 12 and 17 (Figure 2). 
These properties might have qualified epivernodalol to act as a growth inhibitor, as demonstrated in its 
activity against human skin cancer. The inhibitory action of sesquiterpene lactones results from the 
presence  of  highly  electrophilic  functional  groups,  which  according  to  Rodriguez  et  al.  [57], 
selectively  alkylate  by  Michael-type  addition  to  sulphydryl  proteins,  specifically  thiol  groups,  in Int. J. Environ. Res. Public Health 2011, 8        2540 
 
preference to other nucleophiles. Other methods by which Vernonia amygdalina extracts may suppress, 
delay, or kill cancerous cells include induction of apoptosis as determined in cell cultures and animal 
studies  [58,59],  enhanced  chemotherapy  sensitivity  as  Vernonia  amygdalina  extracts  may  render 
cancerous cells to be more sensitive to chemotherapy [59]. Further, down regulation of transcription 
factors have been implicated in the chemopreventive properties of VA. Thus suppression of metastasis 
of cancerous cells in the body by the inhibition of NF-B, which is an anti-apoptotic transcription 
factors  was  demonstrated  in  animal  studies  [59].  The  involvement  of  blood  estrogen  level  in  the 
etiology of estrogen receptor (ER) positive breast cancer has been widely reported and studies have 
shown positive correlations between blood estrogen levels and breast cancer risks [60]. Additional 
source of estrogen production in humans besides the ovary and adrenal gland is the conversion of 
testosterone  to  estrogen  in  a  reaction  catalyzed  by  aromatase.  Therefore,  compounds  that  inhibit 
aromatase activity are used for the treatment of breast cancer since there would be a reduction of 
estrogen level in the body by the suppression of aromatase activity [61]. 
3. Garcinia kola Heckel (Guttiferae) 
3.1. Medicinal Uses of Garcinia kola 
Garcinia kola is largely cultivated tree and highly valued in West and Central Africa for its edible  
nuts [12]. The seed, commonly known, as ‗bitter kola‘ is eaten by many and it is culturally acceptable 
in Nigeria. Extracts of the plant have been employed in the African herbal medicine for the treatment 
of ailments such as laryngitis, liver diseases [13] cough and hoarness of voice [62]. 
The seed is employed as a general tonic and it is believed to have aphrodisiac properties. The roots 
and stems are cut into short chew-sticks used for cleaning teeth. Garcinia kola extract among ten 
common Nigerian chewing sticks examined for antibacterial properties, displayed good activity [24]. 
Garcinia kola seeds have also been indicated in the traditional African medicine in the treatment of 
inflammatory disorders. Extracts of the various parts of the plants have been employed in the treatment 
of laryngitis [12] and liver disease [13]. Extracts of the seeds gave a remarkable improvement of liver 
function in patients with chronic hepatitis and cholangitis after treatment for 14 days at a Nigeria 
herbal home [13]. 
3.2. Biological Properties of Garcinia kola 
Garcinia kola and its extracts have been shown to elicit a number of biological activities in various 
experimental models. Rats chronically fed diets containing powdered seeds of Garcinia kola at the 
level of 10% w/w for 6 weeks displayed marked inhibition of gastrointestinal motility, protection 
against  castor  oil  induced  diarrhea  and  prolonged  pentobarbital  sleeping  time  [63].  Garcinia 
biflavonoid complex, also known as kolaviron (Figure 4) have been shown to elicit hypoglycaemic 
effect on both fasted normoglycemic and alloxan-diabetic rabbits [64]. Also the complex inhibited rat 
lens  aldose  reductase  activity,  an  enzyme  found  in  the  lens  and  other  tissues  which  have  been 
implicated  in  many  diabetic  complications  such  as  neuropathy  and  retinopathy  [64-66].  The 
biflavanones  of  Garcinia  kola  have  been  shown  to  be  pharmacologically  active  with  several 
pharmacokinetic advantages over simple monomeric flavonoids as they survived first-pass metabolism Int. J. Environ. Res. Public Health 2011, 8        2541 
 
which inactivates most flavonoids [67]. In addition to the above notable biological effects of Garcinia 
biflavonoid  complex,  studies  have  also  shown  the  ability  of  this  complex  to  protect  against 
hepatotoxicity  induced  by  phalloidin,  amanita,  2-acetylaminofluorene,  carbon  tetrachloirde, 
paracetamol, aflatoxin, dimethyl nitrosamine in rodents [68-71] (Figure 5).  
Figure 4. Chemical Structure of compounds isolated from Garcinia kola. 
 
Figure 5. Hepatoprotective effects of Garcinia biflavonoids on selected hepatotoxins. 
 
3.3. Chemical Composition of Garcinia kola 
Studies  involving  bioassay-guided  fractionation  of  Garcinia  kola  seed  have  yielded  complex 
mixtures  of  phenolic  compounds,  triterpenes  and  benzophenones.  Aplin  et  al.  [72]  isolated 
cycloartenol and its 24-methylene derivatives from the petroleum spirit extract of the seeds. The ethyl 
acetate-soluble fraction of the acetone extract contains C-3/8‖-link biflavanone GB1, GB2, GB1a and Int. J. Environ. Res. Public Health 2011, 8        2542 
 
kolaflavanone  [73].  These  biflavanones  and  their  glycosides  were  also  isolated  from  the  stem  
back [13]. The ether soluble fraction of the alcoholic extract yielded apigenin-5,7,4‘-trimethyl ether, 
apigenin-4‘-methylether,  fisetin,  amento-flavone,  kolaflavanone  and  GB1  [13].  Benzophenone  and 
kolanone  with  potent  antimicrobial  properties  were  isolated  from  the  light  petroleum  extract  of 
Garcinia  kola  seeds  [74].  Subsequently,  Garcinia  biflavonoid  complex  containing  GB1,  GB2  and 
kolaflavanone, a deffated fraction of alcoholic extract of Garcinia kola seeds was isolated [75]. This 
fraction is also popularly referred to as kolaviron. Recently, GB1 one of the major components of 
Garcinia biflavonoid was isolated from the roots of Garcinia kola. It showed inhibitory effects against 
methicilin-resistant  Staphylococcus  aureus  (MRSA)  and  vancomycin-resistant  enteroccoci  (VRE). 
Terashima et al. [76], also reported two new chromanols, garcinoic acid and garcinal, together with  
-tocotrienol isolated from Garcinia kola seeds (Figure 4). 
3.4. Antioxidant and Radical Scavenging Effects of Garcinia Biflavonoid (kolaviron) 
A  plethora  of  mechanisms  have  been  proposed  and  implicated  in  chemoprevention  of  various 
degenerative diseases including cancer and antioxidant actions have been suggested as one of the 
prominent mechanism. Chemoprevention by natural products against oxidative damage and chemical 
carcinogens may therefore be related to their intrinsic antioxidant properties. Biochemical mechanisms 
underlying chemopreventive properties of Garcinia kola derived- bioflavonoids are shown in Figure 6. 
Figure 6.  Biochemical mechanisms underlying chemopreventive properties of Garcinia 
kola derived-bioflavonoids. 
 
The antioxidant and scavenging activity of Garcinia biflavonoid complex has been investigated in a 
range  of  established  in  vitro  assays  involving  reactive  oxygen  species.  The  study  showed  that 
kolaviron elicited significant reducing power and a dose-dependent inhibition of oxidation of linoleic 
acid [49]. Kolaviron inhibited H2O2, and was more effective than the standard antioxidants BHA and 
-carotene  and  equivalent  in  power  to  -tocopherol.  Kolaviron  also  significantly  scavenged 
superoxide generated by phenazine methosulfate NADH. Furthermore, kolaviron scavenged hydroxyl 
radicals as revealed by significant inhibition of the oxidation of deoxyribose (Figure 7). Hydroxyl 
radical is highly reactive oxygen centered radical, which attacks all proteins, DNA, polyunsaturated Int. J. Environ. Res. Public Health 2011, 8        2543 
 
fatty acids in membranes and almost any biological molecule it touches [74,77]. The inhibitory activity 
of kolaviron in deoxyribose assay may relate directly to prevention of the propagation of the process of 
lipid peroxidation and modulation of other biomarkers of oxidative stress in animal model [68,69]. 
Farombi et al. [78] related the chemoprotective effect of kolaviron to its in vivo antioxidant effects. 
Thus, kolaviron reduced background levels of protein oxidation marker (2-aminoadipic semialdehyde) 
in plasma and liver and -glutamyl semialdehyde (GGS) as well as malondialdehyde in liver [78]. In 
addition, kolaviron reduced damage to proteins and lipids induced by Fe
3+/EDTA/ascorbate mixtures 
ex vivo [79]. 
Figure 7. (A) Inhibition of deoxyribose oxidation by kolaviron and BHA. (B) A plot of 
Reciprocal Absorbance of TBARS at 532 nm against concentration of kolaviron and BHA 
for the Calculation of the rate constants. Values  are  means  SD for three  Experiments. 
(Adapted from Farombi et al. [49]). 
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Furthermore, kolaviron dose dependently inhibited the intracellular ROS production induced by 
H2O2 in HepG2 cells detected as 2‘7‘-dichlorofluorescein diacetate (DCF) fluorescence [80,81]. Thus 
the ability of kolaviron to act as antioxidant in this cell underscores its role as an antioxidant and its 
potential role in the chemoprevention of chemically-induced genotoxicity. 
3.4.1. Effects of Garcinia Biflavonoid on LDL Oxidation and Biomarkers of Oxidative Stress 
Oxidation  of  low-density  lipoprotein  (LDL)  is  generally  believed  to  promote  atherosclerosis, 
primarily  by  leading  to  an  increased  uptake  of  oxidized  LDL  (ox-LDL)  by  macrophages  and 
subsequent  foam  cell  formation  [82].  Therefore,  inhibition  or  reduction  of  the  process  of  LDL 
oxidation may delay the progression of atherosclerosis. Several antioxidants such as vitamin E and C 
and flavonoids have been shown to reduce the in vitro oxidation of LDL. Lipoprotein resistance to 
copper-induced oxidation was highly improved in rats treated with Garcinia biflavonoid (100 mg/kg) 
for 7 days as demonstrated by significant increase in lag time, a decrease in area under the curve (AUC) 
and slope of propagation [82]. Conjugated diene formed after 240 min of lipoprotein oxidation and 
malondialdehyde concentrations were markedly decreased in the Garcinia biflavonoid treated rats with 
attendant  significant  increase  in  the  total  antioxidant  activity  compared  to  control.  In  addition, 
Garcinia biflavonoid (10–60 M) inhibited the Cu
2+-induced oxidation of rat serum lipoprotein in a 
concentration-dependent manner and at the highest dose tested (90 M) elicited a significant chelating 
effect on Fe
2+. Furthermore, Garcinia biflavonoid effectively prevented microsomal lipid peroxidation 
induced  by  iron/ascorbate  in  a  concentration  dependent  manner  [82].  The  data  demonstrate  that 
Garcinia  biflavonoid  protected  against  the  oxidation  of  lipoprotein  presumably  by  mechanisms 
involving metal chelation and antioxidant activity and as such might be of importance in relation to the 
development of atherosclerosis.  
3.4.2. Effects of Kolaviron on Oxidative DNA Damage 
Many chemicals including hydrogen peroxide are known to generate DNA damage through an 
oxygen radical mechanism and can induce chromosomal aberrations, gene mutations and DNA strand 
breaks  [83].  Flavonoid compounds  possessing antioxidant  and  antiradical  activities  are  capable  of 
quenching free radicals, which may promote mutations and DNA damage. Garcinia biflavonoid at 
concentrations between 30–90 µ M decreased H2O2-induced DNA strand breaks and oxidized purine 
(formamidopyrimidine glycosylase (FPG) and pyrimidine (Endonuclease III (ENDO 111) sites) bases 
in  both  human  lymphocytes  and  rat  liver  cells  [79].  Furthermore,  in  lymphocytes  incubated  with 
Fe
3+/GSH, Fe
3+ was reduced to Fe
2+ by GSH initiating a free radical generating reaction which induced 
increases in strand breaks, ENDO III and FPG sensitive sites. However, Garcinia biflavonoid at 30 
and 90 M significantly attenuated GSH/Fe
3+-induced strand breaks as well as base oxidation [79]. In 
addition, Garcinia biflavonoid  ex vivo  protected rat liver cells  against  H2O2-induced  formation  of 
strand  breaks,  ENDO  111,  and  FPG  sensitive  sites.  Farombi  et  al.  [78]  further  demonstrated  the 
protective effect of Garcinia biflavonoid in vivo against oxidative damage to DNA in rat liver. These 
findings  suggest  that  Garcinia  biflavonoid  exhibits  protective  effects  against  oxidative  damage  to 
DNA via scavenging of free radicals and iron binding. 
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Figure  8.  Proposed  mechanism  of  aflatoxin  B1-induced  DNA  damage  (Adapted  from 
Nwankwo et al. [80]). 
 
 
3.5. Chemopreventive Properties of Garcinia Biflavonoid 
3.5.1. Antigenotoxic Effect of Garcinia Biflavonoid 
We  investigated  the  chemopreventive  effects  of  kolaviron,  on  aflatoxin  B1  (AFB1),  a  potent 
hepatocarcinogen  in  experimental  animals  [84]  and  human  carcinogen  [85].  Investigations  of  the 
chemopreventive effects of kolaviron on AFBI induced genotoxicity in rats showed that co-treatment 
of  rats  with  kolaviron  after  AFB1  administration  inhibited  the  induction  of  micronucleated 
polychromatic erythrocytes. In addition, kolaviron inhibited AFB1-induction of markers of hepatic 
oxidative damage [70]. Furthermore, administration of rats with kolaviron alone resulted in significant 
elevation  in  the  activities  of  phase  2  enzymes—glutathione  S-transferase,  uridyl  glucuronosyl 
transferase and NADH:quinone oxidoreductase—by 2.45, 1.62 and1.38-fold, respectively. 
Nwankwo et al. [80] reported the ability of Garcinia biflavonoid to inhibit aflatoxin B1 induced 
genotoxicity in HepG2 cell. AFB1 requires microsomal oxidation to the reactive AFB1-8,9, epoxide 
(AFBO) to exert its hepatocarcinogenic effects (Figure 8). The exo epoxide predominates and it is also 
more genotoxic than the endo form which is also produced [84]. The CYP isozymes involved in the 
metabolism of AFB1 are the 1A2, 3A4 and 3A5 [86]. 1A2 metabolism yields mostly activated epoxide 
metabolite and detoxifies product aflatoxin M1 (AFM1) [84]. The 3A4, which is readily inducible in 
adult human liver [86], is known to yield a higher ratio of AFQ1 to epoxide metabolite than is the case Int. J. Environ. Res. Public Health 2011, 8        2546 
 
for 1A2 at higher substrate concentration. AFBO is detoxified by the activity of GST and GST1-1 
subclass is reputed to be the most abundant form in human liver and kidney and it is inducible by a 
variety of xenobiotics in HepG2 cells [87]. In the study of Nwankwo et al. [80], kolaviron specifically 
induced CYP 3A4. Furthermore, GST isozyme -1 and -2.2 were also induced for their messages as 
determined by Reverse transcription polymerase chain relation (RT-PCR) and northern blot analysis 
and GST  protein by western blotting. These findings explain at least in part the possible molecular 
mechanisms  of  action  of  antigenotoxic  properties  of  kolaviron  and is  in  agreement  with  previous 
reports [69,70]. The findings underscore the role of induction of phase 2 detoxifying enzymes as a 
mechanism of its hepatoprotective action.  
3.5.2. Effect of Garcinia Biflavonoid on Stress Response Proteins and Transcription Factors 
Like  other  early-response  gene  products,  COX-2  can  be  induced  rapidly  and  transiently  by 
proinflammatory mediators, endotoxins as well as carcinogens [80,88]. Inducible nitric oxide synthase 
(iNOS) is another inducible enzyme that causes the overproduction of nitric oxide during inflammation 
and tumor development [89,90]. Therefore, suppression of the induction and activity of COX-2 and/or 
iNOS has been considered a new paradigm in cancer chemoprevention in several organs [90,91].  
Figure 9. Inhibitory effect of kolaviron and curcumin on DMN induced COX-2 expression 
in rat liver (Adapted from Farombi et al. [71]). 
 
Quantification of COX-2 (A) and iNOS (B) immunoblots were normalized to that of actin followed 
by statistical analysis of relative image density in comparison to control. Lane 1, control; lane 2, 
DMN treated; lane 3, kolaviron (100 mg/kg) plus DMN; lane 4, kolaviron (200 mg/kg) plus DMN; 
lane 5, curcumin (200 mg/kg) plus DMN. * P < 0.001 compared with lane 1; ** P < 0.05 compare 
with lane 2; *** P < 0.01 compared with lane 2. 
Recent  findings  on  the  molecular  mechanisms  underlying  hepatoprotective  action  of  kolaviron 
indicate that it can suppress certain proinflammatory genes whose expression have been shown to be 
regulated by transcription factors. Kolaviron abolished the expression of COX-2 and iNOS proteins in 
dimethyl nitrosamine (DMN)-treated rat liver (Figure 9) suggesting that kolaviron may be important Int. J. Environ. Res. Public Health 2011, 8        2547 
 
not only in alleviating liver inflammation but probably for the prevention of liver cancer [71]. NF-B 
is ubiquitous transcription factor that resides in the cytoplasm as heterodimer consisting of p50, p65 
and IBα subunits, Upon activation, it translocates to the nucleus where it induces gene transcription 
[92]. On activation, IBα undergoes phosphorylation and ubiquitination-dependent degradation by 26S 
proteosomes, thus exposing nuclear localization signal on p50-p65 heterodimer, leading to its nuclear 
translocation. In the nucleus, it binds to a specific consensus sequence in the DNA (5,-GGGACTTTC-
3‘) called B binding site. On activation, NF-B induces expression of more than 200 genes including 
COX-2.  The  transcription  factors  NF-B  and  AP-1  have  been  reported  to  be  key  regulators  of 
inflammatory protein such as COX-2 and iNOS [92]. Pretreatment of rats with kolaviron abrogated the 
DNA binding activity of NF-B and AP-1 induced by DMN [71] (Figure 10). 
Figure 10. Inhibitory effects of kolaviron and curcumin on DMN-induced activation of  
NF-B (A) and AP-1 (B) in rat liver (Adapted from Farombi et al. [71]). 
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Lane 1, free probe; lane 2, control; lane 3, DMN alone; lane 4, kolaviron (100 mg/kg) plus DMN; 
lane  5,  kolaviron  (200  mg/kg)  plus  DMN;  lane  6,  curcumin  (200  mg/kg)  plus  DMN;  lane  7, 
competitor. * P < 0.001 compared with lane 2; ** P < 0.001 compared with lane 3. 
Agents that can suppress NF-B and AP-1 have the potential of preventing the onset of cancer [90]. 
Therefore the inhibition of DMN-mediated DNA binding of these transcription factors and expression 
of proinflammatory proteins by kolaviron partly explains the molecular basis of the hepatoprotective 
effect of kolaviron in drug-induced hepatotoxicity and possibly hepatocarcinogenesis and may be an 
additional chemotherapeutic application of the naturally occurring flavonoid. The proposed underlying 
molecular mechanism of hepatoprotective activity of kolaviron [93] is depicted in Figure 11. Int. J. Environ. Res. Public Health 2011, 8        2548 
 
Figure  11.  Proposed  molecular  mechanism  of  hepatoprotective  properties  of  kolaviron 
(Adapted from Farombi [93]). 
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3.5.3. Antiproliferative Potentials of Garcinia Biflavonoid 
Garcinia biflavonoids have been studied for its effects on survival of colon adenoma (LT97) and 
carcinoma-derived (HT29) cell lines. LT 97 cells isolated from micro-adenoma of patient with familiar 
adenoma  polyposis  are  cells  of  an  early  colon  adenoma  in  the  premalignant  stage  of  tumor 
development  whereas  HT29  cell  line  was  established  by  Fogh  and  Trempe  from  a  colon 
adenocarcinoma of a Caucasian female [94]. Preliminary [95] demonstrate that Garcinia biflavonoid 
complex suppressed the growth and survival of both adenoma (LT97) and carcinoma cells (HT29). 
Flavonoid  and  polyphenolic  compounds  have  been  shown  to  elicit  antiproliferative  properties  by 
inhibiting the growth of these cells [96]. The data showed that adenoma cells were more sensitive than 
the transformed carcinoma cells suggesting a higher chemopreventive potential of Garcinia biflavonoid 
mixture in the preneoplastic lesion than the carcinoma. The results showed that the antiproliferative 
effect  of  Garcinia  biflavonoids  may  qualify  the  compounds  as  chemopreventive  agent  against  
colon carcinogenesis. 
4. Conclusions and Future Direction 
A  number  of  chemical  compounds  including  edotides,  and  sesquiterpene  lactones  have  been 
isolated form the leaf of Vernonia amygdalina. Similarly, the bioflavonoid complex otherwise known 
as  kolavion  have  been  characterized  from  the  seed  of  Garcinia  kola.  These  compounds  elicit 
remarkable antioxidant and chemopreventive properties in cell cultures and rodent models. Prominent 
among the biochemical and molecular mechanisms of action of these compounds are elevation of 
phase  II  enzymes,  inhibition  of  cell  proliferation  and  suppression  of  pro-inflammatory  mediators. 
These mechanisms play pivotal role in chemoprevention which appears to be a more pragmatic and Int. J. Environ. Res. Public Health 2011, 8        2549 
 
rational  approach  to  prevention  of  cancer.  Cancer  chemoprevention  has  received  a  phenomenal 
attention in the last three decades by several investigators with focus on evaluating the efficacy of well 
defined  phytochemicals  from  dietary  substances  and  plant  origin  in  various  experimental  models. 
There is also the need to source for new and novel chemopreventive agents from natural origin. In this 
review, the chemopreventive properties of novel compounds from Vernonia amygdalina and Garcinia 
kola have been presented. Their striking underlying and molecular mechanisms support the idea that 
supplements of these compounds may be considered in strategies of using natural products in cancer 
prevention  and  therapy.  Necessary  long-term  clinical  trials  are  therefore  warranted  in  order  to 
showcase potential benefits of Vernonia amygdalina and Garcinia kola-derived phytochemicals as 
chemopreventive agents. Also important is bioavailability of the compounds in Vernonia amygdalina 
and Garcinia kola. However, the biflavanones of Garcinia are pharmacologically active with several 
pharmacokinetic advantages over simple monomeric flavonoids; for instance, the bifavonoids have 
been shown to survive first-pass metabolism which inactivates most flavonoids and they have been 
proved to possess very high thera-peutic potentials [67]. 
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